3-O Sulfated Heparan Sulfate (G2) Peptide Ligand Impairs the Infectivity of <i>Chlamydia muridarum</i>.
<b>Background:</b> Heparan sulfate (HS) is widely implicated as a receptor for <i>Chlamydia</i> cell attachment and infectivity. However, the enzymatic modification of HS modified by the 3-O sulfotransferase-3 (3-OST-3) enzyme in chlamydial cell entry remains unknown. <b>Methodology:</b> To rule out the possibility that host cell 3-O sulfated heparan sulfate (3-OS HS) plays a significant role in <i>C. muridarum</i> entry, a Chinese hamster ovary (CHO-K1) cell model lacking endogenous 3-OST-3 was used. In addition, we further tested the efficacy of the phage-display-derived cationic peptides recognizing heparan sulfate (G1 peptide) and the moieties of 3-O sulfated heparan sulfate (G2 peptide) against <i>C. muridarum</i> entry using human cervical adenocarcinoma (HeLa 229) and human vaginal epithelial (VK2/E6E7) cell lines. Furthermore, molecular dynamics simulations were conducted to investigate the interactions of the <i>Chlamydia</i> lipid bilayer membrane with the G1 and G2 peptides, focusing on their binding modes and affinities. <b>Results:</b> The converse effect of 3-OST-3 expression in the CHO-K1 cells had no enhancing effect on <i>C. muridarum</i> entry. The G2 peptide significantly (>80%) affected the cell infectivity of the elementary bodies (EBs) at all the tested concentrations, as evident from the reduced fluorescent staining in the number of inclusion bodies. The observed neutralization effect of G2 peptide on <i>C. muridarum</i> entry suggests the possibility of sulfated-like domains being present on the EBs. In addition, data generated from our in silico computational structural modeling indicated that the G2 peptide ligand had significant affinity towards the <i>C. muridarum</i> lipid bilayer. <b>Conclusions:</b> Taken together, our findings show that the pretreatment of <i>C. muridarum</i> with 3-O sulfated heparan sulfate recognizing G2 peptide significantly prevents the entry of EBs into host cells.
Authors
- Amber Kaminski (ORCID: https://orcid.org/0000-0003-4181-2972)
- Balbina J. Plotkin (ORCID: https://orcid.org/0000-0002-0564-3975)
- Bajarang Vasant Kumbhar (ORCID: https://orcid.org/0000-0002-3839-9809)
- James Elste (ORCID: https://orcid.org/0000-0002-7970-0485)
- Ira M. Sigar (ORCID: https://orcid.org/0000-0002-1205-8934)
- Vaibhav Tiwari (ORCID: https://orcid.org/0000-0002-8798-6815)
- Purva Khodke (ORCID: https://orcid.org/0000-0002-0250-8030)
- K. Trân Thanh Vân
- Weronika Hanusiak
- Jocelyn Mayen
Institutions
- Midwestern University (US)
- Narsee Monjee Institute of Management Studies (IN)
Publication Details
- Journal
- PubMed
- Published
- 2025-07-12
- DOI
- https://doi.org/10.3390/biom15070999
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00